DIASORIN DEUTSCHLAND GMBH

Diasorin Deutschland GmbH specializes in the manufacturing of in vitro diagnostic (IVD) surgical supplies and laboratory testing systems, with a focus on automated immunoassay platforms and reagent kits designed for clinical and defense medical environments. Their technical expertise centers on high-throughput diagnostic kits, including the RPP NXTAG system, which enables rapid, multiplexed detection of infectious agents and biomarkers using chemiluminescent technology. The company demonstrates deep proficiency in regulatory-compliant production of IVD devices aligned with U.S. FDA and military medical standards, ensuring reliability in point-of-care and deployed field settings. Their key differentiator lies in the integration of standardized, scalable diagnostic platforms that support consistent performance under operational constraints, making their solutions suitable for military health readiness and expeditionary medical logistics. The contractor has delivered diagnostic solutions exclusively to the Department of Defense, providing mission-critical in vitro diagnostic test systems that support force health protection, infectious disease surveillance, and battlefield medical triage. These engagements reflect a consistent partnership focused on equipping military medical units with validated, ready-to-use diagnostic tools that meet stringent military specifications for durability, traceability, and rapid deployment. The primary NAICS code 339113 reflects their role as a manufacturer of surgical and diagnostic medical devices, specifically IVD reagents and assay kits. Their vertical specialization is in immunoassay-based diagnostics for infectious disease detection, positioning them within the defense and public health diagnostics market as a precision manufacturing provider for standardized, high-compliance medical test systems. Diasorin Deutschland GmbH operates as a foreign-owned subsidiary with its headquarters in Dietzenbach, Germany. While no U.S. government certifications are listed, their products are engineered to meet U.S. military diagnostic requirements and are distributed through established federal supply channels. Their market presence is defined by technical alignment with DoD medical logistics needs rather than domestic regulatory registrations.